Report cover image

Biopharmaceutical CMO and CRO Market, By Source (Mammalian and Non-mammalian), By Service (Contract Manufacturing and Contract Research), and By Product (Biologics and Biosimilars), and By Geography (North America, Europe, Asia Pacific, Latin America, and

Publisher Coherent Market Insights
Published May 21, 2025
Length 160 Pages
SKU # CMI20081373

Description

Biopharmaceutical CMO (Contract Manufacturing Organization) is a company that serves other companies in the biopharmaceutical sector on a contract basis to offer services ranging from drug manufacturing services to packaging. While, Contract Research Organization (CRO) is a company that provides support to biopharmaceutical companies in the form of research services outsourced on a contract basis.

Market Dynamics:

Rise in burden of chronic diseases, increasing drug discovery and development, increasing demand for biologics and biosimilars, growing trend of outsourcing, increasing investment in research and development and the rapid growth of the biopharmaceutical industry are major factors expected to augment the growth of the global biopharmaceutical CMO and CRO market.

For instance, in February 2023, Lunaphore and Sirona Dx announced a strategic collaboration in which Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore’s flagship COMET spatial biology platform as a service. A COMET will complement Sirona Dx’s portfolio of research service offerings to meet the needs of researchers and biopharma teams across various disciplines. COMET has a wide range of research applications across multiple disciplines and all stages of research and drug development.

Key features of the study:
  • This report provides in-depth analysis of the global biopharmaceutical CMO and CRO market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global biopharmaceutical CMO and CRO market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include AlcheraBio, Alcami, Akos Urgent Care, Agilent, AGC Biologics, Affinity Life Sciences, Inc., Actimus Bio, ACI Clinical, Accumedix, Inc., Allphase Clinical Research, Absorption Systems, A10 Clinical Solutions, Albuquerque Clinical Trials (ACT), Ajinomoto Bio-Pharma Services, Advanced Clinical Services LLC, ACM Global Laboratories, Accelerated Enrollment Solutions, AbbVie Contract Manufacturing, Advanced BioScience Laboratories, Advanced Clinical Research Institute, and Alliance for Clinical Trials in Oncology, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global biopharmaceutical CMO and CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharmaceutical CMO and CRO market.
Detailed Segmentation:
  • Global Biopharmaceutical CMO and CRO Market, By Source:
  • Mammalian
  • Non-mammalian
  • Global Biopharmaceutical CMO and CRO Market, By Service:
  • Contract Manufacturing
  • Contract Research
  • Global Biopharmaceutical CMO and CRO Market, By Product:
  • Biologics
  • Biosimilars
  • Global Biopharmaceutical CMO and CRO Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles:
  • Allphase Clinical Research
  • AlcheraBio
  • Alcami
  • Akos Urgent Care
  • Agilent
  • AGC Biologics
  • Affinity Life Sciences, Inc.
  • Actimus Bio
  • ACI Clinical
  • Accumedix, Inc.
  • Absorption Systems
  • A10 Clinical Solutions
  • Albuquerque Clinical Trials (ACT)
  • Ajinomoto Bio-Pharma Services
  • Advanced Clinical Services LLC
  • ACM Global Laboratories
  • Accelerated Enrollment Solutions
  • AbbVie Contract Manufacturing
  • Advanced BioScience Laboratories
  • Advanced Clinical Research Institute
  • Alliance for Clinical Trials in Oncology

Table of Contents

160 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Source
Market Snapshot, By Service
Market Snapshot, By Product
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Growing trend of outsourcing across the globe
Stringent regulatory framework
Rapid growth of the biopharmaceutical industry
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Biopharmaceutical CMO and CRO Market, By Source, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Mammalian
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Non-mammalian
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
5. Global Biopharmaceutical CMO and CRO Market, By Service, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Contract Manufacturing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Contract Research
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global Biopharmaceutical CMO and CRO Market, By Product, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Biologics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Biosimilars
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Biopharmaceutical CMO and CRO Market, By Region, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Service, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
South Africa
North Africa
Central Africa
8. Competitive Landscape
Allphase Clinical Research
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AlcheraBio
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Alcami
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Akos Urgent Care
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Agilent
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AGC Biologics
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Affinity Life Sciences, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Actimus Bio
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
ACI Clinical
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Accumedix, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Absorption Systems
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
A10 Clinical Solutions
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Albuquerque Clinical Trials (ACT)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Ajinomoto Bio-Pharma Services
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Advanced Clinical Services LLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
ACM Global Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Accelerated Enrollment Solutions
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AbbVie Contract Manufacturing
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Advanced BioScience Laboratories
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Advanced Clinical Research Institute
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Alliance for Clinical Trials in Oncology
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
9. Section
Research Methodology
About us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us